Lipocine Inc.
LPCN
$2.11
$0.052.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.85M | -11.43M | -9.63M | -5.48M | -4.51M |
| Total Depreciation and Amortization | 58.50K | 60.00K | 60.80K | 61.40K | 55.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.40K | 5.70K | 49.50K | 39.80K | -177.80K |
| Change in Net Operating Assets | 633.40K | 1.32M | -243.50K | 234.70K | -357.20K |
| Cash from Operations | -11.19M | -10.05M | -9.76M | -5.14M | -4.99M |
| Capital Expenditure | -- | -- | -- | -10.00K | -90.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.15M | -3.13M | 5.89M | 5.09M | 5.49M |
| Cash from Investing | -6.15M | -3.13M | 5.89M | 5.08M | 5.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.27M | 14.84M | 2.87M | 216.90K | 75.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 16.27M | 14.84M | 2.87M | 216.90K | 75.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.06M | 1.66M | -1.00M | 158.20K | 490.70K |